What happens if you take nattokinase every day?

Take nattokinase every day and, according to clinical research, the most measurable changes happen quietly inside your bloodstream — where the enzyme nudges your body's own clot-clearing system into a higher gear.

In a randomized trial of 86 adults, 2,000 FU of nattokinase daily lowered systolic blood pressure by about 5.55 mmHg over 8 weeks, and a single dose raises fibrin-breakdown markers within hours. But the dramatic benefits you may have read about depend heavily on dose — and that distinction is the whole story.

Table of Contents

1. What Nattokinase Does in Your Body
2. What Happens to Your Blood Pressure
3. What Happens to Clotting and Circulation
4. Cholesterol and Plaque: Why Dose Changes the Answer
5. Is It Safe to Take Nattokinase Every Day?
6. How Much to Take, and in What Form
7. A Clinically Studied Dose You Can Take Once a Day
8. Frequently Asked Questions
9. Conclusion
10. Research References

What Nattokinase Does in Your Body

Nattokinase is a fibrinolytic enzyme — a protein that breaks down fibrin, the mesh that holds blood clots together — originally isolated from the fermented soybean food natto in 1987. In laboratory tests, it cleaves cross-linked fibrin roughly 6 times more efficiently than plasmin, the body's own clot-dissolving enzyme.

Beyond cutting fibrin directly, nattokinase works upstream: it inactivates PAI-1, the main brake on your natural clot-clearing system, which frees up tissue plasminogen activator (tPA) to do its job. That dual action is why researchers often describe it less as a clot-buster and more as a way to keep your own fibrinolysis running smoothly.

A fair question is whether an enzyme can survive digestion at all. In a controlled crossover study, a single 2,000 FU dose raised fibrin degradation products within about 4 hours and increased antithrombin levels — evidence that enough reaches the bloodstream to have a real effect.

What Happens to Your Blood Pressure

Blood pressure is where daily nattokinase has its most credible, repeatable effect. In the randomized, placebo-controlled trial of 86 adults with pre- or stage-1 hypertension, 8 weeks of 2,000 FU daily lowered systolic pressure by 5.55 mmHg and diastolic by 2.84 mmHg compared with placebo.

A single trial can be a fluke, so the more useful number comes from pooling studies. A meta-analysis of 6 randomized trials and 546 participants found an average systolic reduction of 3.45 mmHg and diastolic of 2.32 mmHg, with no notable adverse events reported across the studies.

To be clear about scale: a 3-to-5 mmHg drop is meaningful across a population but modest for any one person. It is a supporting strategy, not a replacement for prescribed blood-pressure medication or lifestyle change. Our full review of nattokinase and blood pressure breaks the trials down one by one.

What Happens to Clotting and Circulation

Taken consistently, nattokinase appears to shift several clotting markers in a "thinner" direction. In an 8-week study of 45 people taking 2,000 FU twice daily, healthy participants saw fibrinogen fall about 9%, factor VII about 14%, and factor VIII about 17%.

This is not the same as a pharmaceutical clot-buster. Nattokinase shows fibrin specificity, meaning that at studied doses it supports normal fibrin turnover rather than aggressively stripping the blood of clotting factors — which helps explain why pooled trials at typical doses report no notable bleeding events in otherwise healthy people. That same activity, though, is exactly what makes it risky to combine with blood thinners, as the safety section below explains.

Some effects appear within a single day: after one dose, D-dimer rose at the 6-hour and 8-hour marks, indicating active fibrin breakdown rather than a change that takes weeks to build.

Cholesterol and Plaque: Why Dose Changes the Answer

This is where most online claims get slippery. The most eye-catching results come from a retrospective study of 1,062 people who took 10,800 FU daily for 12 months, which reported LDL cholesterol down about 18%, carotid artery wall thickness down about 22%, and plaque size down roughly 36%.

Two caveats matter. First, that dose is more than five times a standard 2,000 FU capsule, and the same study found that its lower 3,600 FU dose produced essentially no change in lipids or plaque. Second, it was a retrospective analysis with industry funding — a useful signal, but not the gold standard of a controlled trial.

When researchers ran that gold-standard test at the common dose, the picture changed: a randomized controlled trial found that 2,000 FU daily did not slow subclinical atherosclerosis in lower-risk adults. The honest takeaway is that nattokinase's dramatic cardiovascular claims rest on high doses and weaker study designs, while everyday 2,000 FU use is best understood as gentle fibrinolytic and blood-pressure support. For how these effects fit into the bigger cardiovascular picture, see nattokinase for heart health.

Is It Safe to Take Nattokinase Every Day?

For most healthy adults not on blood thinners, daily nattokinase has a reassuring short-term safety record: even the 12-month, high-dose study recorded no significant adverse effects across 1,062 participants, and pooled trials at standard doses found the same.

The real caution is bleeding risk in combination with other drugs. Memorial Sloan Kettering flags a theoretical increase in bleeding when nattokinase is taken with anticoagulant, antiplatelet, or fibrinolytic medications, and drug-safety references note a reported case of cerebellar hemorrhage, along with Health Canada's concern about vitamin-K-free formulations. Nattokinase should never replace a prescribed anticoagulant — a patient who substituted it for warfarin after a mechanical valve replacement developed a dangerous valve clot.

Practical rules follow from this: speak with your doctor first if you take blood thinners or have a bleeding disorder, stop nattokinase before any surgery, and avoid it during pregnancy or nursing, where safety data are lacking. If you are considering it alongside anticoagulants, our guide to nattokinase as a natural blood thinner covers those interactions in detail.

How Much to Take, and in What Form

Most clinical research uses 2,000 FU as a single daily unit — the dose behind the blood-pressure and fibrinolytic findings above — while the lipid and plaque effects appear only at much higher intakes of roughly 6,000 to 12,000 FU per day. FU (fibrinolytic units) measure enzyme activity, not weight, so two products at the same 100 mg dose can differ in potency.

Timing and delivery matter too. Nattokinase is typically taken once daily, and because it is a protein that stomach acid can degrade, a delivery format that protects the enzyme until it reaches the small intestine supports absorption. Many people take it on an empty stomach for this reason.

One more practical note: if you already supplement with vitamin K2 or take medication, a nattokinase product that is intentionally K2-free removes one interaction variable to think about — though, again, anyone on blood thinners should confirm the plan with a clinician before starting.

A Clinically Studied Dose You Can Take Once a Day

If the research points anywhere practical for everyday use, it is toward the 2,000 FU dose that most blood-pressure and fibrinolytic studies actually tested — delivered in a form that survives the stomach. BioAbsorb's Nattokinase Enzyme provides exactly that: 100 mg standardized to 2,000 FU of activity per capsule, taken once daily on an empty stomach.

Rather than a traditional enteric coating, it uses DRcaps delayed-release veggie capsules, which shield the enzyme from stomach acid without the phthalates and plasticizers found in some coated capsules, delivering it intact to the small intestine. The formula is intentionally free of vitamin K2 — helpful if you are managing K2 intake separately — and free of gluten, nuts, eggs, dairy, fish, shellfish, and all animal products.

Every batch is third-party tested for nattokinase activity, heavy metals, and microbial contaminants, and made in a Canadian GMP-certified facility. It comes in 60- and 180-count sizes, making it straightforward to take the studied dose consistently — which is what the evidence rewards.

Frequently Asked Questions

Is it safe to take nattokinase every day?

For healthy adults not on blood thinners, generally yes — clinical trials at typical doses report no notable adverse events, and a 12-month study at a high dose recorded no significant adverse effects across 1,062 people. The main exceptions are those taking anticoagulant or antiplatelet drugs, who should consult a physician first.

How quickly does nattokinase work?

Some effects are fast: a single 2,000 FU dose raised clot-breakdown markers within 4 to 8 hours. Blood-pressure changes, by contrast, showed up over roughly 8 weeks of daily use, and any lipid or plaque changes take months.

Can I take nattokinase with warfarin or other blood thinners?

Not without medical supervision. Nattokinase's fibrinolytic activity can add to a blood thinner's effect, and there are documented cases of both bleeding and clotting complications. It should never be used as a replacement for a prescribed anticoagulant.

Does nattokinase lower cholesterol?

The evidence is mixed and dose-dependent. High doses in a retrospective study lowered LDL by about 18%, but a meta-analysis found no clear lipid benefit at lower doses.

Should I stop nattokinase before surgery?

Yes. Because it affects clotting, clinicians generally advise pausing fibrinolytic supplements before procedures. Ask your provider how many days ahead to stop.

Is a 2,000 FU dose actually enough?

It is the dose behind most of the blood-pressure and fibrinolytic evidence, so it is a reasonable everyday choice — but the stronger cholesterol and plaque results required higher doses, and more controlled trials are still needed to settle the question.

Conclusion

Taken every day at the commonly studied 2,000 FU dose, nattokinase's best-supported effects are enhanced fibrinolysis and a modest blood-pressure reduction of about 3 to 5 mmHg, while bigger cardiovascular claims depend on higher doses and weaker evidence. If that fits your goals, the practical move is a consistent, clinically studied dose in a delivery form that survives digestion — and a conversation with your doctor first if you take any blood thinner. You can explore BioAbsorb's 2,000 FU Nattokinase Enzyme here.

Research References

1. Effects of Nattokinase on Blood Pressure: A Randomized, Controlled Trial. Hypertension Research, Vol. 31 (2008). An 8-week randomized controlled trial in 86 adults found that 2,000 FU daily reduced systolic and diastolic blood pressure versus placebo.
2. Nattokinase Supplementation and Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Reviews in Cardiovascular Medicine, Vol. 24 (2023). Pooled 6 randomized trials (546 participants), finding a modest but consistent blood-pressure reduction and no notable adverse events.
3. Effective Management of Atherosclerosis Progress and Hyperlipidemia with Nattokinase: A Clinical Study with 1,062 Participants. Frontiers in Cardiovascular Medicine, Vol. 9 (2022). Retrospective study reporting lipid and carotid-plaque improvements at 10,800 FU/day over 12 months, with no benefit at 3,600 FU/day.
4. Nattokinase Atherothrombotic Prevention Study (NAPS): A Randomized Controlled Trial. Clinical Hemorheology and Microcirculation, Vol. 78 (2021). Found that 2,000 FU daily did not slow subclinical atherosclerosis progression in lower-risk adults.
5. Nattokinase Decreases Plasma Levels of Fibrinogen, Factor VII, and Factor VIII in Human Subjects. Nutrition Research, Vol. 29 (2009). Daily nattokinase reduced key clotting factors over 8 weeks in healthy and at-risk participants.
6. A Single-Dose of Oral Nattokinase Potentiates Thrombolysis and Anti-Coagulation Profiles. Scientific Reports, Vol. 5 (2015). Demonstrated that oral nattokinase is absorbed intact and raises fibrinolytic markers within hours of a single dose.
7. Nattokinase: A Promising Alternative in Prevention and Treatment of Cardiovascular Diseases. Biomarker Insights, Vol. 13 (2018). Review of nattokinase's fibrinolytic, antihypertensive, and anti-atherosclerotic mechanisms and clinical relevance.
8. The Profibrinolytic Enzyme Subtilisin NAT Cleaves and Inactivates Plasminogen Activator Inhibitor Type 1. Journal of Biological Chemistry, Vol. 276 (2001). Identified nattokinase's inactivation of PAI-1 as a route to enhanced natural fibrinolysis.
9. Consequence of Patient Substitution of Nattokinase for Warfarin After Aortic Valve Replacement with a Mechanical Prosthesis. Proceedings (Baylor University Medical Center), Vol. 28 (2015). Case report of prosthetic-valve thrombosis after a patient replaced warfarin with nattokinase.
10. Nattokinase — About Herbs. Memorial Sloan Kettering Cancer Center, Integrative Medicine (accessed 2026). Clinical summary of nattokinase's mechanism and its theoretical bleeding-risk drug interactions.
11. Nattokinase — Uses, Benefits & Dosage. Drugs.com Natural Products (accessed 2026). Drug-information overview covering safety, reported bleeding cases, and vitamin-K considerations.

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.

---

Important Disclaimers

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.